Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial

Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial

Objectives: This report describes the baseline clinical profiles and management of DELIVER (Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure) trial participants and how these compare with those in other contemporary heart failure with preserved...

Full description

Bibliographic Details
Main Authors: Al Habeeb, W. (Author), Alcocer Gamba, M.A (Author), Belohlavek, J. (Author), Cabrera Honorio, J.W (Author), Chiang, C.-E (Author), Claggett, B.L (Author), Comin-Colet, J. (Author), de Boer, R.A (Author), DeMets, D. (Author), Dobreanu, D. (Author), Drozdz, J. (Author), Fang, J.C (Author), Han, Y. (Author), Hernandez, A.F (Author), Inzucchi, S.E (Author), Janssens, S.P (Author), Katova, T. (Author), Kerr Saraiva, J.F (Author), Kitakaze, M. (Author), Kosiborod, M.N (Author), Lam, C.S.P (Author), Lindholm, D. (Author), Martinez, F. (Author), McMurray, J.J.V (Author), Merkely, B. (Author), O'Meara, E. (Author), Petersson, M. (Author), Shah, S.J (Author), Solomon, S.D (Author), Tereschenko, S.N (Author), Thierer, J. (Author), Vaduganathan, M. (Author), Vardeny, O. (Author), Verma, S. (Author), Vinh, P.N (Author), Wilderäng, U. (Author), Willem Borleffs, C.J (Author), Zaozerska, N. (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
adult
aged
amino terminal pro brain natriuretic peptide
angiotensin receptor antagonist
Article
atrial fibrillation
beta adrenergic receptor blocking agent
body mass
cardiovascular mortality
clinical effectiveness
clinical feature
clinical trials
controlled study
dapagliflozin
dipeptidyl carboxypeptidase inhibitor
double blind procedure
female
heart failure with mildly reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with reduced ejection fraction
high risk patient
hospital admission
human
major clinical study
male
medical history
mineralocorticoid antagonist
New York Heart Association class
non insulin dependent diabetes mellitus
parallel design
placebo
protein blood level
randomized controlled trial
SGLT-2 inhibitors
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items